The immunology of pregnancy: Regulatory T cells control maternal immune tolerance toward the fetus

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 41-48

  La Rocca, Claudia ^a,b   Carbone, Fortunata ^b   Longobardi, Salvatore ^c   Matarese, Giuseppe ^d,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c Merck Serono SpA   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

^e IRCCS MULTIMEDICA   (Italy)

Author keywords

Immune tolerance; Pregnancy; Recurrent miscarriage; Regulatory T cells

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRIOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PROGESTERONE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; HORMONE;

CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; HORMONE ACTION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; INFERTILITY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MOTHER FETUS RELATIONSHIP; NONHUMAN; PREECLAMPSIA; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SEMINAL PLASMA; SPONTANEOUS ABORTION; T LYMPHOCYTE SUBPOPULATION; TH1 TH2 BALANCE; TH17 CELL; ANIMAL; FEMALE; FETUS; HISTOCOMPATIBILITY; IMMUNOLOGY; METABOLISM; MOUSE; PREGNANCY; SPERM;

ANIMALS; CYTOKINES; FEMALE; FETUS; HISTOCOMPATIBILITY, MATERNAL-FETAL; HORMONES; HUMANS; IMMUNE TOLERANCE; IMMUNOMODULATION; MICE; PREGNANCY; SEMEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84908458584     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.06.013     Document Type: Review

References (109)

1. Tafuri A., Alferink J., Möller P., Hämmerling G.J., Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995, 270:630-633.
2. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998, 281:1191-1193.
3. Ban Y., Chang Y., Dong B., Kong B., Qu X. Indoleamine 2,3-dioxygenase levels at the normal and recurrent spontaneous abortion fetal-maternal interface. J Int Med Res 2013, 41:1135-1149.
4. Dürr S., Kindler V. Implication of indolamine 2,3 dioxygenase in the tolerance toward fetuses, tumors, and allografts. J Leukoc Biol 2013, 93:681-687.
5. Mellor A.L., Munn D.H. Extinguishing maternal immune responses during pregnancy: implications for immunosuppression. Semin Immunol 2001, 13:213-218.
6. Mackler A.M., Barber E.M., Takikawa O., Pollard J.W. Indoleamine 2,3-dioxygenase is regulated by IFN-gamma in the mouse placenta during Listeria monocytogenes infection. J Immunol 2003, 170:823-830.
7. Baban B., Chandler P., McCool D., Marshall B., Munn D.H., Mellor A.L. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 2004, 61:67-77.
8. Hunt J.S., Vassmer D., Ferguson T.A., Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997, 158:4122-4128.
9. Rouas-Freiss N., Gonçalves R.M., Menier C., Dausset J., Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997, 94:11520-11525.
10. Kopcow H.D., Allan D.S., Chen X., Rybalov B., Andzelm M.M., Ge B., et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA 2005, 102:15563-15568.
11. Vacca P., Pietra G., Falco M., Romeo E., Bottino C., Bellora F., et al. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood 2006, 108:4078-4085.
12. Xu C., Mao D., Holers V.M., Palanca B., Cheng A.M., Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000, 287:498-501.
13. Erlebacher A., Vencato D., Price K.A., Zhang D., Glimcher L.H. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest 2007, 117:1399-1411.
14. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
15. Wing K., Sakaguchi S. Regulatory T cells exert checks and balances on self-tolerance and autoimmunity. Nat Immunol 2010, 11:7-13.
16. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
17. Gershon R.K., Cohen P., Hencin R., Liebhaber S.A. Suppressor T cells. J Immunol 1972, 108:586-590.
18. Shevach E.M. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
19. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400.
20. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001, 182:18-32.
21. Josefowicz S.Z., Lu L.F., Rudensky A.Y. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012, 30:531-564.
22. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
23. Roncador G., Brown P.J., Maestre L., Hue S., Martínez-Torrecuadrada J.L., Ling K.L., et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005, 35:1681-1691.
24. Gambineri E., Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003, 15:430-435.
25. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
26. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007, 445:766-770.
27. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007, 8:277-284.
28. Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nat Immunol 2005, 6:353-360.
29. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003, 3:199-210.
30. Takahashi T., Kuniyasu Y., Toda M., Sakaguchi N., Itoh M., Iwata M., et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998, 10:1969-1980.
31. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998, 188:287-296.
32. Bopp T., Becker C., Klein M., Klein-Hessling S., Palmetshofer A., Serfling E., et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007, 204:1303-1310.
33. Deaglio S., Dwyer K.M., Gao W., Friedman D., Usheva A., Erat A., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007, 204:1257-1265.
34. Paust S., Lu L., McCarty N., Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci USA 2004, 101:10398-10403.
35. Oderup C., Cederbom L., Makowska A., Cilio C.M., Ivars F. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. Immunology 2006, 118:240-249.
36. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002, 3:1097-1101.
37. Lohr J., Knoechel B., Abbas A.K. Regulatory T cells in the periphery. Immunol Rev 2006, 212:149-162.
38. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009, 206:3015-3029.
39. Somerset D.A., Zheng Y., Kilby M.D., Sansom D.M., Drayson M.T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004, 112:38-43.
40. Santner-Nanan B., Peek M.J., Khanam R., Richarts L., Zhu E., Fazekas de St.Groth B., et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009, 183:7023-7030.
41. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004, 5:266-271.
42. Shima T., Sasaki Y., Itoh M., Nakashima A., Ishii N., Sugamura K., et al. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol 2010, 85:121-129.
43. Winger E.E., Reed J.L. Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure. Am J Reprod Immunol 2011, 66:320-328.
44. Jin L.P., Chen Q.Y., Zhang T., Guo P.F., Li D.J. The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage. Clin Immunol 2009, 133:402-410.
45. Jasper M.J., Tremellen K.P., Robertson S.A. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod 2006, 12:301-308.
46. Zenclussen A.C., Gerlof K., Zenclussen M.L., Sollwedel A., Bertoja A.Z., Ritter T., et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 2005, 166:811-822.
47. Teles A., Thuere C., Wafula P.O., El-Mousleh T., Zenclussen M.L., Zenclussen A.C. Origin of Foxp3(+) cells during pregnancy. Am J Clin Exp Immunol 2013, 2:222-233.
48. Vacca P., Cantoni C., Vitale M., Prato C., Canegallo F., Fenoglio D., et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc Natl Acad Sci USA 2010, 107:11918-11923.
49. Zheng Y., Josefowicz S., Chaudhry A., Peng X.P., Forbush K., Rudensky A.Y. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463:808-812.
50. Samstein R.M., Josefowicz S.Z., Arvey A., Treuting P.M., Rudensky A.Y. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 2012, 150:29-38.
51. Rowe J.H., Ertelt J.M., Xin L., Way S.S. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 2012, 490:102-106.
52. Trupin L.S., Simon L.P., Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology 1996, 7:240-244.
53. Schumacher A., Wafula P.O., Bertoja A.Z., Sollwedel A., Thuere C., Wollenberg I., et al. Mechanisms of action of regulatory T cells specific for paternal antigens during pregnancy. Obstet Gynecol 2007, 110:1137-1145.
54. Mold J.E., Michaëlsson J., Burt T.D., Muench M.O., Beckerman K.P., Busch M.P., et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008, 322(December (5907)):1562-1565.
55. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998, 339:285-291.
56. Soldan S.S., Alvarez Retuerto A.I., Sicotte N.L., Voskuhl R.R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 2003, 171:6267-6274.
57. Mattsson R., Mattsson A., Holmdahl R., Whyte A., Rook G.A. Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen induced arthritis. Autoimmunity 1991, 85:41-47.
58. Latham K.A., Zamora A., Drought H., Subramanian S., Matejuk A., Offner H., et al. Estradiol treatment redirects the isotype of the autoantibody response and prevents the development of autoimmune arthritis. J Immunol 2003, 171:5820-5827.
59. Offner H. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. J Neurosci 2004, 78:603-624.
60. Offner H., Adlard K., Zamora A., Vandenbark A.A. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J Clin Invest 2000, 105:1465-1472.
61. Ito A., Buenafe A.C., Matejuk A., Zamora A., Silverman M., Dwyer J., et al. Estrogen inhibits systemic T cell expression of TNF-alpha and recruitment of TNF-alpha(+) T cells and macrophages into the CNS of mice developing experimental encephalomyelitis. Clin Immunol 2002, 102:275-282.
62. Bebo B.F., Fyfe-Johnson A., Adlard K., Beam A.G., Vandenbark A.A., Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 2001, 166:2080-2089.
63. Polanczyk M.J., Carson B.D., Subramanian S., Afentoulis M., Vandenbark A.A., Ziegler S.F., et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004, 173:2227-2230.
64. Polanczyk M.J., Hopke C., Huan J., Vandenbark A.A., Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol 2005, 170:85-92.
65. Tai P., Wang J., Jin H., Song X., Yan J., Kang Y., et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 2008, 214:456-464.
66. Shirshev S.V., Orlova E.G., Zamorina S.A., Nekrasova I.V. Influence of reproductive hormones on the induction of CD4(+)CD25(bright)Foxp(3+) regulatory T cells. Dokl Biol Sci 2011, 440:343-346.
67. Schumacher A., Brachwitz N., Sohr S., Engeland K., Langwisch S., Dolaptchieva M., et al. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol 2009, 182:5488-5497.
68. Healy D.L., Okamato S., Morrow L., Thomas A., Jones M., McLachlan V., et al. Contributions of in vitro fertilization to knowledge of the reproductive endocrinology of the menstrual cycle. Baillieres Clin Endocrinol Metab 1987, 1:133-152.
69. Khil L.Y., Jun H.S., Kwon H., Yoo J.K., Kim S., Notkins A.L., et al. Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. Diabetologia 2007, 50:2147-2155.
70. De Rosa V., Procaccini C., Calì G., Pirozzi G., Fontana S., Zappacosta S., et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007, 26:241-255.
71. Procaccini C., De Rosa V., Galgani M., Abanni L., Calì G., Porcellini A., et al. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 2010, 33:929-941.
72. Boots C., Stephenson M.D. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med 2011, 29:507-513.
73. Wang W.J., Hao C.F., Yi-Lin Yin G.J., Bao S.H., Qiu L.H., et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol 2010, 84:164-170.
74. Piccinni M.P., Beloni L., Livi C., Maggi E., Scarselli G., Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998, 4:1020-1024.
75. Kühn R., Rajewsky K., Müller W. Generation and analysis of interleukin-4 deficient mice. Science 1991, 254:707-710.
76. Svensson L., Arvola M., Sällström M.A., Holmdahl R., Mattsson R. The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol 2001, 51:3-7.
77. White C.A., Johansson M., Roberts C.T., Ramsay A.J., Robertson S.A. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod 2004, 70:123-131.
78. Nakashima A., Ito M., Shima T., Bac N.D., Hidaka T., Saito S. Accumulation of IL-17-positive cells in decidua of inevitable abortion cases. Am J Reprod Immunol 2010, 64:4-11.
79. Liu F., Guo J., Tian T., Wang H., Dong F., Huang H., et al. Placental trophoblasts shifted Th1/Th2 balance toward Th2 and inhibited Th17 immunity at fetomaternal interface. APMIS 2011, 119:597-604.
80. Wang W.J., Hao C.F., Qu Q.L., Wang X., Qiu L.H., Lin Q.D. The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod 2010, 25:2591-2596.
81. Kastelein R.A., Hunter C.A., Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007, 25:221-242.
82. Wang W.J., Liu F.J., Qu H.M., Hao C.F., Qu Q.L., Xiong-Wang, et al. Regulation of the expression of Th17 cells and regulatory T cells by IL-27 in patients with unexplained early recurrent miscarriage. J Reprod Immunol 2013, 99:39-45.
83. Murugaiyan G., Mittal A., Lopez-Diego R., Maier L.M., Anderson D.E., Weiner H.L. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 2009, 183:2435-2443.
84. Mas A.E., Petitbarat M., Dubanchet S., Fay S., Ledée N., Chaouat G. Immune regulation at the interface during early steps of murine implantation: involvement of two new cytokines of the IL-12 family (IL-23 and IL-27) and of TWEAK. Am J Reprod Immunol 2008, 59:323-338.
85. Robertson S.A., Care A.S., Skinner R.J. Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod 2007, 76:738-748.
86. Saito S., Nakashima A., Shima T., Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010, 63:601-610.
87. Desai N., Scarrow M., Lawson J., Kinzer D., Goldfarb J. Evaluation of the effect of interleukin-6 and human extracellullar matrix on embryonic development. Hum Reprod 1999, 14:1588-1592.
88. Jacobs A.L., Sehgal P.B., Julian J., Carson D.D. Secretion and hormonal regulation of interleukin-6 production by mouse uterine stromal and polarized epithelial cells cultured in vitro. Endocrinology 1992, 131:1037-1046.
89. Masuhiro K., Matsuzaki N., Nishino E., Taniguchi T., Kameda T., Li Y., et al. Trophoblast-derived interleukin-1 (IL-1) stimulates the release of human chorionic gonadotropin by activating IL-6 and IL-6-receptor system in first trimester human trophoblasts. J Clin Endocrinol Metab 1991, 72:594-601.
90. Robertson S.A., Guerin L.R., Moldenhauer L.M., Hayball J.D. Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid. J Reprod Immunol 2009, 83:109-116.
91. Robertson S.A. Seminal plasma and male factor signalling in the female reproductive tract. Cell Tissue Res 2005, 322:43-52.
92. + T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 2009, 80:1036-1045.
93. Moldenhauer L.M., Diener K.R., Thring D.M., Brown M.P., Hayball J.D., Robertson S.A. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol 2009, 182:8080-8093.
94. Hutter H., Dohr G.H.L.A. expression on immature and mature human germ cells. J Reprod Immunol 1998, 38:101-122.
95. Robertson S.A., Ingman W.V., O'Leary S., Sharkey D.J., Tremellen K.P. Transforming growth factor beta - a mediator of immune deviation in seminal plasma. J Reprod Immunol 2002, 57:109-128.
96. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
97. Clark D.A., Fernandes J., Banwatt D. Prevention of spontaneous abortion in the CBA×DBA/2 mouse model by intravaginal TGF-beta and local recruitment of CD4+8+ FOXP3+ cells. Am J Reprod Immunol 2008, 59:525-534.
98. Sánchez-Ramón S., Navarro A.J., Aristimuño C., Rodríguez-Mahou M., Bellón J.M., Fernández-Cruz E., et al. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. Immunol Lett 2005, 96:195-201.
99. Förger F., Marcoli N., Gadola S., Möller B., Villiger P.M., Ostensen M. Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis 2008, 67:984-990.
100. Zhou J.Z., Zhao X., Wang J., Sun H., Hu Y. An increase of Treg cells in the peripheral blood is associated with a better in vitro fertilization treatment outcome. Am J Reprod Immunol 2012, 68:100-106.
101. Battaglia M., Stabilini A., Roncarolo M.G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005, 105:4743-4748.
102. Yin Y., Han X., Shi Q., Zhao Y., He Y. Adoptive transfer of CD4+CD25+ regulatory T cells for prevention and treatment of spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 2012, 161:177-181.
103. Novales J.S., Salva A.M., Modanlou H.D., Kaplan D.L., del Castillo J., Andersen J., et al. Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection. Blood 1993, 81:923-927.
104. Litwin S., Lagadari M., Barrientos G., Roux M.E., Margni R., Miranda S. Comparative immunohistochemical study of M-CSF and G-CSF in feto-maternal interface in a multiparity mouse model. Am J Reprod Immunol 2005, 54:311-320.
105. Sugita K., Hayakawa S., Karasaki-Suzuki M., Hagiwara H., Chishima F., Aleemuzaman S., et al. Granulocyte colony stimulation factor (G-CSF) suppresses interleukin (IL)-12 and/or IL-2 induced interferon (IFN)-gamma production and cytotoxicity of decidual mononuclear cells. Am J Reprod Immunol 2003, 50:83-89.
106. McCracken S.A., Grant K.E., MacKenzie I.Z., Redman C.W., Mardon H.J. Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta. Biol Reprod 1999, 60:790-796.
107. Scarpellini F., Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 2009, 24:2703-2708.
108. Toh H.C., Sun L., Soe Y., Wu Y., Phoon Y.P., Chia W.K., et al. G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo. Clin Immunol 2009, 132:83-92.
109. Rossetti M., Gregori S., Roncarolo M.G. Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells. Eur J Immunol 2010, 40:3097-3106.